Literature DB >> 21502961

Atrial fibrillation. Left atrial fibrosis--a promising stroke risk factor?

Fiorenzo Gaita1, Alessandro Blandino.   

Abstract

The pathophysiological properties of the left atrium are not usually considered for stroke risk stratification of patients with atrial fibrillation. The demonstration that left atrial fibrosis detected by delayed-enhancement MRI is associated with history of stroke highlights the need to take into account histopathological data, in addition to clinical data, in stroke risk stratification.

Entities:  

Mesh：

Year:  2011        PMID： 21502961     DOI： 10.1038/nrcardio.2011.63

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  10 in total

Review 1.  Independent predictors of stroke in patients with atrial fibrillation: a systematic review.

Authors: 
Journal:  Neurology       Date:  2007-08-07       Impact factor: 9.910

2.  Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

Authors:  R G Hart; O Benavente; R McBride; L A Pearce
Journal:  Ann Intern Med       Date:  1999-10-05       Impact factor: 25.391

3.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

4.  Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation.

Authors:  Marcos Daccarett; Troy J Badger; Nazem Akoum; Nathan S Burgon; Christian Mahnkopf; Gaston Vergara; Eugene Kholmovski; Christopher J McGann; Dennis Parker; Johannes Brachmann; Rob S Macleod; Nassir F Marrouche
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

5.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

6.  Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.

Authors:  Margaret C Fang; Alan S Go; Yuchiao Chang; Leila Borowsky; Niela K Pomernacki; Daniel E Singer
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

7.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

Review 8.  Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation.

Authors: 
Journal:  Stroke       Date:  2008-04-17       Impact factor: 7.914

9.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

Review 10.  Atrial fibrillation and stroke prevention.

Authors:  Gregory Y H Lip; Hoong Sern Lim
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182
  10 in total
  1 in total

1.  Different influence of cardiac hemodynamics on thromboembolic events in patients with paroxysmal and non-paroxysmal atrial fibrillation.

Authors:  Yun Gi Kim; Jaemin Shim; Ki Yung Boo; Do Young Kim; Suk-Kyu Oh; Kwang-No Lee; Jong-Il Choi; Young-Hoon Kim
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.